Isolation and characterization of cyclic lipopeptides with broad-spectrum antimicrobial activity from Bacillus siamensis JFL15.
Ben-Hong XuZhi-Wei YeQian-Wang ZhengTao WeiJun-Fang LinLi-Qiong GuoPublished in: 3 Biotech (2018)
In this research, the antimicrobial substance anti-JFL15 was partially purified using a simple two-step extraction process from the cell-free supernatants of Bacillus siamensis JFL15. Anti-JFL15 exhibited a strong antibacterial activity against various multidrug-resistant aquatic bacterial pathogens, including Escherichia coli, Edwardsiella tarda, Pseudomonas aeruginosa, Aeromonas hydrophila, and Vibrio. Liquid chromatography-mass spectrometry revealed that anti-JFL15 contained eight cyclic lipopeptides belonging to two families: bacillomycin F (m/z 1056.56-1084.59) and surfactin (m/z 1007.65-1049.70) analogs. PCR analysis showed the presence of genes (i.e., sfp gene, surfactin synthetase D, fengycin synthetase B, iturin synthetase A, iturin synthetase C and bacillomycin synthetase D) involved in the biosynthesis of cyclic lipopeptides. This study is the first to identify cyclic lipopeptides from B. siamensis and use them to suppress the growth of various multidrug-resistant aquatic bacterial pathogens. Results indicated that B. siamensis JFL15 is a promising biocontrol agent for the effective and environmentally friendly control of various multidrug-resistant aquatic bacterial pathogens.
Keyphrases
- multidrug resistant
- gram negative
- acinetobacter baumannii
- mass spectrometry
- drug resistant
- liquid chromatography
- cell free
- bacillus subtilis
- klebsiella pneumoniae
- pseudomonas aeruginosa
- escherichia coli
- risk assessment
- biofilm formation
- genome wide
- staphylococcus aureus
- genome wide identification
- single cell
- high performance liquid chromatography
- high resolution
- transcription factor
- capillary electrophoresis
- dna methylation
- silver nanoparticles
- molecular dynamics simulations
- simultaneous determination
- genome wide analysis
- ms ms